Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction

European Journal of Heart Failure

Volumn 18, Issue 8, 2016, Pages 987-997

  Primessnig, Uwe ^a,b,c   Schönleitner, Patrick ^b,d   Höll, Alexander ^b   Pfeiffer, Susanne ^b   Bracic, Taja ^b   Rau, Thomas ^b   Kapl, Martin ^b   Stojakovic, Tatjana ^b   Glasnov, Toma ^e   Leineweber, Kirsten ^f   Wakula, Paulina ^a,c   Antoons, Gudrun ^b,d   Pieske, Burkert ^a,b,c   Heinzel, Frank R ^a,b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF GRAZ   (Austria)

^f BAYER PHARMA AG   (Germany)

Author keywords

Active relaxation; Calcium; Cardiomyocyte; Diastolic dysfunction; Heart failure with preserved ejection fraction; Na+ Ca2+ exchanger; SEA0400

Indexed keywords

2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; CAFFEINE; CALCIUM ION; SODIUM CALCIUM EXCHANGE PROTEIN;

ACUTE DRUG ADMINISTRATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIORENAL SYNDROME; CELL FUNCTION; CHRONIC DRUG ADMINISTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART VENTRICLE REMODELING; IN VITRO STUDY; IN VIVO STUDY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUNG CONGESTION; LUNG WEIGHT; MALE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT MODEL; RELAXATION TIME; UPREGULATION;

EID: 84981731311     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.524     Document Type: Article

References (28)

1. Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, Love TE, Aban IB, Shlipak MG. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007;99:393–398.
2. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263–271.
3. Dostal DE, Watson LE. Understanding diastolic heart failure with preserved ejection fraction: choosing the right model. Hypertension 2006;47:830–832.
4. Heinzel FR, Luo Y, Dodoni G, Boengler K, Petrat F, Di LF, de GH, Schulz R, Heusch G. Formation of reactive oxygen species at increased contraction frequency in rat cardiomyocytes. Cardiovasc Res 2006;71:374–382.
5. Hohendanner F, Ljubojevic S, Macquaide N, Sacherer M, Sedej S, Biesmans L, Wakula P, Platzer D, Sokolow S, Herchuelz A, Antoons G, Sipido K, Pieske B, Heinzel FR. Intracellular dyssynchrony of diastolic cytosolic [Ca(2)(+)] decay in ventricular cardiomyocytes in cardiac remodeling and human heart failure. Circ Res 2013;113:527–538.
6. Bourgonje VJ, Vos MA, Ozdemir S, Doisne N, Acsai K, Varro A, Sztojkov-Ivanov A, Zupko I, Rauch E, Kattner L, Bito V, Houtman M, van der Nagel R, Beekman JD, van Veen TA, Sipido KR, Antoons G. Combined Na(+)/Ca(2+) exchanger and L-type calcium channel block as a potential strategy to suppress arrhythmias and maintain ventricular function. Circ Arrhythm Electrophysiol 2013;6:371–379.
7. Acsai K, Kun A, Farkas AS, Fulop F, Nagy N, Balazs M, Szentandrassy N, Nanasi PP, Papp JG, Varro A, Toth A. Effect of partial blockade of the Na(+)/Ca(2+)-exchanger on Ca(2+) handling in isolated rat ventricular myocytes. Eur J Pharmacol 2007;576:1–6.
8. Lavine SJ, Prcevski P, Held AC, Johnson V. Experimental model of chronic global left ventricular dysfunction secondary to left coronary microembolization. J Am Coll Cardiol 1991;18:1794–1803.
9. Damman K, Tang WH, Felker GM, Lassus J, Zannad F, Krum H, McMurray JJ. Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. J Am Coll Cardiol 2014;63:853–871.
10. Sharkovska Y, Kalk P, Lawrenz B, Godes M, Hoffmann LS, Wellkisch K, Geschka S, Relle K, Hocher B, Stasch JP. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models. J Hypertens 2010;28:1666–1675.
11. Tyralla K, Adamczak M, Benz K, Campean V, Gross ML, Hilgers KF, Ritz E, Amann K. High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy. PLoS One 2011; 6:e15287.
12. Amann K, Tyralla K, Gross ML, Schwarz U, Tornig J, Haas CS, Ritz E, Mall G. Cardiomyocyte loss in experimental renal failure: prevention by ramipril. Kidney Int 2003;63:1708–1713.
13. Donohoe P, McMahon AC, Walgama OV, Bertaso F, Dockrell ME, Cramp HA, Mullen AM, Shattock MJ, Hendry BM, James AF. L-type calcium current of isolated rat cardiac myocytes in experimental uraemia. Nephrol Dial Transplant 2000;15:791–798.
14. Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC, Malhotra D, Xie Z, Shapiro JI. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol 2003;14:90–97.
15. Sacherer M, Sedej S, Wakula P, Wallner M, Vos M, Kockskamper J, Stiegler P, Sereinigg M, von LD, Antoons G, Pieske B, Heinzel F. JTV519 (K201) reduces sarcoplasmic reticulum Ca(2+) leak and improves diastolic function in vitro in murine and human non-failing myocardium. Br J Pharmacol 2012;167:493–504.
16. Grantham CJ, Cannell MB. Ca2+ influx during the cardiac action potential in guinea pig ventricular myocytes. Circ Res 1996;79:194–200.
17. Larbig R, Torres N, Bridge JH, Goldhaber JI, Philipson KD. Activation of reverse Na + −Ca2+ exchange by the Na + current augments the cardiac Ca2+ transient: evidence from NCX knockout mice. J Physiol 2010;588:3267–3276.
18. Weisser-Thomas J, Piacentino V, III, Gaughan JP, Margulies K, Houser SR. Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes. Cardiovasc Res 2003;57:974–985.
19. McMahon AC, Naqvi RU, Hurst MJ, Raine AE, MacLeod KT. Diastolic dysfunction and abnormality of the Na+/Ca2+ exchanger in single uremic cardiac myocytes. Kidney Int 2006;69:846–851.
20. Despa S, Bers DM. Na(+) transport in the normal and failing heart - remember the balance. J Mol Cell Cardiol 2013;61:2–10.
21. Hamlyn JM, Manunta P. Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis. Adv Chronic Kidney Dis 2015;22:232–244.
22. Sedej S, Schmidt A, Denegri M, Walther S, Matovina M, Arnstein G, Gutschi EM, Windhager I, Ljubojevic S, Negri S, Heinzel FR, Bisping E, Vos MA, Napolitano C, Priori SG, Kockskamper J, Pieske B. Subclinical abnormalities in sarcoplasmic reticulum Ca(2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload. J Am Coll Cardiol 2014;63:1569–1579.
23. Borbely A, van dV, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005;111:774–781.
24. Detsky ME, Azevedo ER, Parker JD. Left ventricular isovolumic relaxation is a predictor of left ventricular end-diastolic pressure. Can J Cardiol 2003;19:378–382.
25. Kamimura D, Ohtani T, Sakata Y, Mano T, Takeda Y, Tamaki S, Omori Y, Tsukamoto Y, Furutani K, Komiyama Y, Yoshika M, Takahashi H, Matsuda T, Baba A, Umemura S, Miwa T, Komuro I, Yamamoto K. Ca2+ entry mode of Na+/Ca2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction. Eur Heart J 2012;33:1408–1416.
26. Bisping E, Wakula P, Poteser M, Heinzel FR. Targeting cardiac hypertrophy: towards a causal heart failure therapy. J Cardiovasc Pharmacol 2014;64:293–305.
27. Titze S, Schmid M, Kottgen A, Busch M, Floege J, Wanner C, Kronenberg F, Eckardt KU. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transplant 2015;30:441–451.
28. Unger ED, Dubin RF, Deo R, Daruwalla V, Friedman JL, Medina C, Beussink L, Freed B, Shah SJ. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 2015;18:103–112.